BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27129171)

  • 1. Emblica officinalis extract downregulates pro-angiogenic molecules via upregulation of cellular and exosomal miR-375 in human ovarian cancer cells.
    De A; Powers B; De A; Zhou J; Sharma S; Van Veldhuizen P; Bansal A; Sharma R; Sharma M
    Oncotarget; 2016 May; 7(21):31484-500. PubMed ID: 27129171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitization of Carboplatinum- and Taxol-Resistant High-Grade Serous Ovarian Cancer Cells Carrying p53, BRCA1/2 Mutations by Emblica officinalis (Amla) via Multiple Targets.
    De A; De A; Sharma R; Suo W; Sharma M
    J Cancer; 2020; 11(7):1927-1939. PubMed ID: 32194804
    [No Abstract]   [Full Text] [Related]  

  • 3. Emblica officinalis extract induces autophagy and inhibits human ovarian cancer cell proliferation, angiogenesis, growth of mouse xenograft tumors.
    De A; De A; Papasian C; Hentges S; Banerjee S; Haque I; Banerjee SK
    PLoS One; 2013; 8(8):e72748. PubMed ID: 24133573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-1294 confers cisplatin resistance in ovarian Cancer cells by targeting IGF1R.
    Zhang Y; Huang S; Guo Y; Li L
    Biomed Pharmacother; 2018 Oct; 106():1357-1363. PubMed ID: 30119207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer.
    Kanlikilicer P; Bayraktar R; Denizli M; Rashed MH; Ivan C; Aslan B; Mitra R; Karagoz K; Bayraktar E; Zhang X; Rodriguez-Aguayo C; El-Arabey AA; Kahraman N; Baydogan S; Ozkayar O; Gatza ML; Ozpolat B; Calin GA; Sood AK; Lopez-Berestein G
    EBioMedicine; 2018 Dec; 38():100-112. PubMed ID: 30487062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells.
    Dong P; Xiong Y; Watari H; Hanley SJ; Konno Y; Ihira K; Yamada T; Kudo M; Yue J; Sakuragi N
    J Exp Clin Cancer Res; 2016 Sep; 35(1):132. PubMed ID: 27596137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R.
    Gong Y; Ren J; Liu K; Tang LM
    World J Gastroenterol; 2015 Mar; 21(10):2949-58. PubMed ID: 25780292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomal release of microRNA-454 by breast cancer cells sustains biological properties of cancer stem cells via the PRRT2/Wnt axis in ovarian cancer.
    Wang L; He M; Fu L; Jin Y
    Life Sci; 2020 Sep; 257():118024. PubMed ID: 32598931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Snail-Modulated MicroRNA 493 Forms a Negative Feedback Loop with the Insulin-Like Growth Factor 1 Receptor Pathway and Blocks Tumorigenesis.
    Kumar AS; Jagadeeshan S; Pitani RS; Ramshankar V; Venkitasamy K; Venkatraman G; Rayala SK
    Mol Cell Biol; 2017 Mar; 37(6):. PubMed ID: 27956702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-630 inhibitor sensitizes chemoresistant ovarian cancer to chemotherapy by enhancing apoptosis.
    Eoh KJ; Lee SH; Kim HJ; Lee JY; Kim S; Kim SW; Kim YT; Nam EJ
    Biochem Biophys Res Commun; 2018 Mar; 497(2):513-520. PubMed ID: 29452092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs.
    Rashed MH; Kanlikilicer P; Rodriguez-Aguayo C; Pichler M; Bayraktar R; Bayraktar E; Ivan C; Filant J; Silva A; Aslan B; Denizli M; Mitra R; Ozpolat B; Calin GA; Sood AK; Abd-Ellah MF; Helal GK; Berestein GL
    Oncotarget; 2017 Mar; 8(12):20145-20164. PubMed ID: 28423620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-associated fibroblasts secrete FGF-1 to promote ovarian proliferation, migration, and invasion through the activation of FGF-1/FGFR4 signaling.
    Sun Y; Fan X; Zhang Q; Shi X; Xu G; Zou C
    Tumour Biol; 2017 Jul; 39(7):1010428317712592. PubMed ID: 28718374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential of peptide-engineered exosomes with overexpressed miR-92b-3p in anti-angiogenic therapy of ovarian cancer.
    Wang J; Wang C; Li Y; Li M; Zhu T; Shen Z; Wang H; Lv W; Wang X; Cheng X; Xie X
    Clin Transl Med; 2021 May; 11(5):e425. PubMed ID: 34047469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-181a upregulation is associated with epithelial-to-mesenchymal transition (EMT) and multidrug resistance (MDR) of ovarian cancer cells.
    Li L; Xu QH; Dong YH; Li GX; Yang L; Wang LW; Li HY
    Eur Rev Med Pharmacol Sci; 2016 May; 20(10):2004-10. PubMed ID: 27249598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-223-3p Regulates Ovarian Cancer Cell Proliferation and Invasion by Targeting SOX11 Expression.
    Fang G; Liu J; Wang Q; Huang X; Yang R; Pang Y; Yang M
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docosahexaenoic acid (DHA) inhibits pro-angiogenic effects of breast cancer cells via down-regulating cellular and exosomal expression of angiogenic genes and microRNAs.
    Aslan C; Maralbashi S; Kahroba H; Asadi M; Soltani-Zangbar MS; Javadian M; Shanehbandi D; Baradaran B; Darabi M; Kazemi T
    Life Sci; 2020 Oct; 258():118094. PubMed ID: 32673663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Egr-1 mediates epidermal growth factor-induced downregulation of E-cadherin expression via Slug in human ovarian cancer cells.
    Cheng JC; Chang HM; Leung PC
    Oncogene; 2013 Feb; 32(8):1041-9. PubMed ID: 22508482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reinforcement of invasion in epithelial ovarian cancer cells by 17 beta-Estradiol is associated with up-regulation of Snail.
    Ding JX; Feng YJ; Yao LQ; Yu M; Jin HY; Yin LH
    Gynecol Oncol; 2006 Nov; 103(2):623-30. PubMed ID: 16806441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor.
    Zhao X; Dou W; He L; Liang S; Tie J; Liu C; Li T; Lu Y; Mo P; Shi Y; Wu K; Nie Y; Fan D
    Oncogene; 2013 Mar; 32(11):1363-72. PubMed ID: 22614005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.
    Liu X; Li G
    Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.